Literature DB >> 22526182

[Organ-limited prostate cancer with positive resection margins. Importance of adjuvant radiation therapy].

D Porres1, D Pfister, B Brehmer, A Heidenreich.   

Abstract

For pT3 prostate cancer with positive resection margins, the importance of postoperative radiation therapy is confirmed by a high level of evidence. However, for the pT2,R1 situation prospective, randomized studies concerning this question are lacking. Despite better local tumor control in the pT2 stage the PSA recurrence rate lies between 25% and 40% and positive margins are an independent factor for recurrence. Retrospective studies suggest a positive effect of adjuvant or salvage radiation for the oncological outcome in the pT2,R1 situation. On the other hand the side effects profile, with a potentially negative influence of postoperative continence and various delayed toxicities, is not insignificant despite modern radiation techniques and in the era of ultrasensitive PSA analysis should be considered in the risk-benefit assessment. As long as the optimal initiation of postoperative radiation therapy is unclear, the assessment of indications for adjuvant or salvage radiation for organ-limited prostate cancer with positive resection margins should be made after an individual patient consultation and under consideration of the recurrence risk factors, such as the Gleason grade and the localization and extent of the resection margins.

Entities:  

Mesh:

Year:  2012        PMID: 22526182     DOI: 10.1007/s00120-012-2871-0

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  37 in total

1.  Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients.

Authors:  Pierre I Karakiewicz; James A Eastham; Markus Graefen; Ilias Cagiannos; Phillip D Stricker; Eric Klein; Thomas Cangiano; Fritz H Schröder; Peter T Scardino; Michael W Kattan
Journal:  Urology       Date:  2005-12       Impact factor: 2.649

2.  Overall survival benefit from postoperative radiation therapy for organ-confined, margin-positive prostate cancer.

Authors:  Robert O Dillman; Russell Hafer; Craig Cox; Stephanie E McClure
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-14       Impact factor: 7.038

3.  Ability of linear length of positive margin in radical prostatectomy specimens to predict biochemical recurrence.

Authors:  Dengfeng Cao; Peter A Humphrey; Feng Gao; Yu Tao; Adam S Kibel
Journal:  Urology       Date:  2011-01-22       Impact factor: 2.649

4.  [Radiation therapy for prostate cancer in the new S3 guideline. Part 2: postoperative radiation therapy and brachytherapy].

Authors:  T Martin; F Wenz; D Böhmer; F Sedlmayer; W Hinkelbein; T O Henkel; K Miller; T Wiegel
Journal:  Urologe A       Date:  2010-02       Impact factor: 0.639

5.  Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.

Authors:  P Kupelian; J Katcher; H Levin; C Zippe; E Klein
Journal:  Urology       Date:  1996-08       Impact factor: 2.649

6.  High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.

Authors:  Richard Savdie; Lisa G Horvath; Ruth Pe Benito; Krishan K Rasiah; Anne-Maree Haynes; Mark Chatfield; Phillip D Stricker; Jennifer J Turner; Warwick Delprado; Susan M Henshall; Robert L Sutherland; James G Kench
Journal:  BJU Int       Date:  2011-10-12       Impact factor: 5.588

7.  A multi-institutional analysis comparing adjuvant and salvage radiation therapy for high-risk prostate cancer patients with undetectable PSA after prostatectomy.

Authors:  Tom Budiharto; Christiaan Perneel; Karin Haustermans; Sara Junius; Bertrand Tombal; Pierre Scalliet; Laurette Renard; Evelyne Lerut; Kris Vekemans; Steven Joniau; Hendrik Van Poppel
Journal:  Radiother Oncol       Date:  2010-10-13       Impact factor: 6.280

8.  [Value of positive resection margins in patients with pT2 prostate cancer. Implications for adjuvant treatment].

Authors:  J E Rosas-Nava; F Herranz-Amo; E V Paños-Fagundo; E Lledó-García; F Verdú-Tartajo; C Hernández-Fernández
Journal:  Actas Urol Esp       Date:  2011-03-12       Impact factor: 0.994

9.  Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.

Authors:  Hendrik Isbarn; Manuela Wanner; Georg Salomon; Thomas Steuber; Thorsten Schlomm; Jens Köllermann; Guido Sauter; Alexander Haese; Hans Heinzer; Hartwig Huland; Markus Graefen
Journal:  BJU Int       Date:  2009-12-11       Impact factor: 5.588

10.  Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.

Authors:  Thomas Wiegel; Dirk Bottke; Ursula Steiner; Alessandra Siegmann; Reinhard Golz; Stephan Störkel; Norman Willich; Axel Semjonow; Rainer Souchon; Michael Stöckle; Christian Rübe; Lothar Weissbach; Peter Althaus; Udo Rebmann; Tilman Kälble; Horst Jürgen Feldmann; Manfred Wirth; Axel Hinke; Wolfgang Hinkelbein; Kurt Miller
Journal:  J Clin Oncol       Date:  2009-05-11       Impact factor: 44.544

View more
  1 in total

1.  Impact of positive surgical margin on biochemical recurrence in localized prostate cancer.

Authors:  Wonchul Lee; Bumjin Lim; Yoon Soo Kyung; Choung-Soo Kim
Journal:  Prostate Int       Date:  2021-03-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.